Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Memorial Sloan Kettering Cancer Center
New York, NY 10065
Summary
- Physician scientist and hematology/oncologist with research experience in inflammation, immunity and targeted therapy resistance.
Global Development Medical Director/ clinical lead in pharma developing novel antibody-drug conjugates, T-cell engagers and IOs therapy in solid tumors.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2017 - 2022
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2015 - 2017
David Geffen School of Medicine at UCLAClass of 2015
University of California, BerkeleyBS, Biology, Summa Cum Laude- California Institute of TechnologyPhD, Immunology
Certifications & Licensure
NY State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Prostate cancer foundation Young Investigator Award
- ASCO Young Investigator Award
Publications & Presentations
PubMed
- 6 citationsSingle-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.Samir Zaidi, Jooyoung Park, Joseph M Chan, Martine P Roudier, Jimmy L Zhao
Proceedings of the National Academy of Sciences of the United States of America. 2024-07-09 - 4 citationsAssessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates.Azra Ajkunic, Erolcan Sayar, Martine P Roudier, Radhika A Patel, Ilsa M Coleman
NPJ Precision Oncology. 2024-05-17 - 1 citationsSingle Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies.Samir Zaidi, Jooyoung Park, Joseph M Chan, Martine P Roudier, Jimmy L Zhao
Biorxiv. 2024-04-12
Press Mentions
The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer ResearchDecember 16th, 2020
Keeping Stem Cells Strong: RNA Molecule Protects Stem Cells During InflammationMay 21st, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
